Market Cap 144.72B
Revenue (ttm) 22.60B
Net Income (ttm) 2.99B
EPS (ttm) N/A
PE Ratio 29.97
Forward PE 28.12
Profit Margin 13.25%
Debt to Equity Ratio 0.80
Volume 1,746,000
Avg Vol 1,299,696
Day's Range N/A - N/A
Shares Out 381.69M
Stochastic %K 90%
Beta 0.91
Analysts Strong Sell
Price Target $431.77

Company Profile

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the t...

Industry: Medical Devices
Sector: Healthcare
Phone: (269) 385-2600
Fax: (269) 385-1062
Address:
1941 Stryker Way, Portage, United States
SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
StockAutoPro
StockAutoPro Jun. 16 at 11:34 PM
$SYK: Trading at $377.12, stable. Buy near $375, target $380 with medical devices demand steady.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 11 at 11:36 AM
Projected 90-day price trend outlook for $SYK, based on historical performance patterns and recent earnings-related momentum. #stocks #trading #investing
0 · Reply
zoey1970
zoey1970 Jun. 10 at 9:43 AM
$INTC Whisker Wisdom: How Rat-Inspired AI Redefines Robotics In the perilous realm of search and rescue, where every second counts amidst crumbling structures or toxic fumes, human responders face daunting risks. Similarly, monitoring hazardous environments, be it tracking pollution plumes or assessing volatile chemical leaks demands precision in unforgiving conditions. Traditional methods, reliant on human courage or static sensor networks, often fall short under these pressures. Enter robotics, m A new study, Self-powered artificial vibrissal system with anemotaxis behavior by Meng Qi and colleagues, published in Science Advances (4 June 2025), unearths a bioinspired solution that harnesses rat-like sensory prowess to redefine robotic capabilities. Read more here if interested... https://neuromorphiccore.ai/whisker-wisdom-how-rat-inspired-ai-redefines-robotics/ #AI, #Autonomous, #BioinspiredRobotics, #Neuromorphic, #Robotics, #Sensors $MCHP, $ZBRA, $ABB, $SYK,
0 · Reply
rich54
rich54 Jun. 9 at 4:19 PM
$CRMD Next CRMD is $MBOT It got a small disappointment today but it is positioned exactly like CRMD few months/quarters ago. Both could be targets of acquisition by $SYK Holding both & hoping for great future ahead
1 · Reply
Gorohanada
Gorohanada Jun. 9 at 3:14 PM
$SYK They are doing millions of knee replacements in India
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 8 at 3:40 AM
$SYK With surgical robotics, rising dividends, & expansion, Stryker is becoming a healthcare titan. Here's why SYK can be your next winning move. https://biotechhealthx.com/biotech-news/stryker-syk-is-quietly-dominating-the-medtech-industry-heres-what-investors-need-to-know/
0 · Reply
Marcusjoback
Marcusjoback May. 29 at 9:53 PM
Just look at $MBOT Massive Total Addressable Market and $ISRG $SYK & $GEHC can’t compete with our Remote LIBERTY technology patents that essentially eliminate radiation effects and acquiring us for our IP won’t be cheap! ✌️
0 · Reply
roejohn
roejohn May. 29 at 6:17 PM
$SYK $SENS , has an approved implantable CGM , FDA and Medicare . The combination of SYK and SENS makes sense . SENS is a necessity ! EVERSENSE 365
0 · Reply
Ro_Patel
Ro_Patel May. 26 at 6:04 PM
Drawdowns & recoveries of US stocks w/ highest & lowest total shareholder returns from 1985 to 2024 $BRO $SYK $EXPD $SHW $AMGN Note: Many of the big tech co.s today, such as Tesla and even Amazon & Nvidia, had their IPOs much later than 1985
1 · Reply
Latest News on SYK
Stryker declares an $0.84 per share quarterly dividend

May 8, 2025, 8:00 AM EDT - 6 weeks ago

Stryker declares an $0.84 per share quarterly dividend


Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:28 PM EDT - 7 weeks ago

Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript


Stryker reports first quarter 2025 operating results

May 1, 2025, 4:05 PM EDT - 7 weeks ago

Stryker reports first quarter 2025 operating results


Stryker completes sale of U.S. spinal implants business

Apr 1, 2025, 4:05 PM EDT - 3 months ago

Stryker completes sale of U.S. spinal implants business


Stryker announces Annual Meeting of Shareholders

Mar 25, 2025, 4:15 PM EDT - 3 months ago

Stryker announces Annual Meeting of Shareholders


The Big 3: MMM, PM, SYK

Mar 18, 2025, 1:01 PM EDT - 3 months ago

The Big 3: MMM, PM, SYK

MMM PM


Stryker launches Steri-Shield 8 personal protection system

Mar 4, 2025, 8:07 AM EST - 4 months ago

Stryker launches Steri-Shield 8 personal protection system


Stryker launches Sync Badge

Mar 3, 2025, 8:07 AM EST - 4 months ago

Stryker launches Sync Badge


The Big 3: FTNT, NXT, SYK

Feb 20, 2025, 12:14 PM EST - 4 months ago

The Big 3: FTNT, NXT, SYK

FTNT NXT


Kadant Set to Join S&P SmallCap 600

Feb 13, 2025, 5:54 PM EST - 4 months ago

Kadant Set to Join S&P SmallCap 600

KAI


Sales Growth, Strategic Acquisitions Drive Stryker Higher

Jan 31, 2025, 4:34 PM EST - 5 months ago

Sales Growth, Strategic Acquisitions Drive Stryker Higher


Overlooked Stock: SYK

Jan 28, 2025, 4:45 PM EST - 5 months ago

Overlooked Stock: SYK


Stryker reports 2024 operating results and 2025 outlook

Jan 28, 2025, 4:05 PM EST - 5 months ago

Stryker reports 2024 operating results and 2025 outlook


Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

Jan 6, 2025, 5:19 PM EST - 6 months ago

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion


Stryker Bringing in Big Money

Nov 20, 2024, 3:21 AM EST - 7 months ago

Stryker Bringing in Big Money


Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 8:37 PM EDT - 8 months ago

Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript


Stryker: A High Quality MedTech Name Investors Should Own

Oct 17, 2024, 10:42 AM EDT - 8 months ago

Stryker: A High Quality MedTech Name Investors Should Own


Stryker: More Earnings Growth And Higher Prices Ahead

Oct 17, 2024, 7:45 AM EDT - 8 months ago

Stryker: More Earnings Growth And Higher Prices Ahead


Stryker's Acquisition Spree: Double-Digit Growth on the Horizon

Oct 11, 2024, 3:25 PM EDT - 9 months ago

Stryker's Acquisition Spree: Double-Digit Growth on the Horizon


Stryker to announce its third quarter 2024 financial results

Oct 1, 2024, 4:00 PM EDT - 9 months ago

Stryker to announce its third quarter 2024 financial results


SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
StockAutoPro
StockAutoPro Jun. 16 at 11:34 PM
$SYK: Trading at $377.12, stable. Buy near $375, target $380 with medical devices demand steady.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 11 at 11:36 AM
Projected 90-day price trend outlook for $SYK, based on historical performance patterns and recent earnings-related momentum. #stocks #trading #investing
0 · Reply
zoey1970
zoey1970 Jun. 10 at 9:43 AM
$INTC Whisker Wisdom: How Rat-Inspired AI Redefines Robotics In the perilous realm of search and rescue, where every second counts amidst crumbling structures or toxic fumes, human responders face daunting risks. Similarly, monitoring hazardous environments, be it tracking pollution plumes or assessing volatile chemical leaks demands precision in unforgiving conditions. Traditional methods, reliant on human courage or static sensor networks, often fall short under these pressures. Enter robotics, m A new study, Self-powered artificial vibrissal system with anemotaxis behavior by Meng Qi and colleagues, published in Science Advances (4 June 2025), unearths a bioinspired solution that harnesses rat-like sensory prowess to redefine robotic capabilities. Read more here if interested... https://neuromorphiccore.ai/whisker-wisdom-how-rat-inspired-ai-redefines-robotics/ #AI, #Autonomous, #BioinspiredRobotics, #Neuromorphic, #Robotics, #Sensors $MCHP, $ZBRA, $ABB, $SYK,
0 · Reply
rich54
rich54 Jun. 9 at 4:19 PM
$CRMD Next CRMD is $MBOT It got a small disappointment today but it is positioned exactly like CRMD few months/quarters ago. Both could be targets of acquisition by $SYK Holding both & hoping for great future ahead
1 · Reply
Gorohanada
Gorohanada Jun. 9 at 3:14 PM
$SYK They are doing millions of knee replacements in India
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 8 at 3:40 AM
$SYK With surgical robotics, rising dividends, & expansion, Stryker is becoming a healthcare titan. Here's why SYK can be your next winning move. https://biotechhealthx.com/biotech-news/stryker-syk-is-quietly-dominating-the-medtech-industry-heres-what-investors-need-to-know/
0 · Reply
Marcusjoback
Marcusjoback May. 29 at 9:53 PM
Just look at $MBOT Massive Total Addressable Market and $ISRG $SYK & $GEHC can’t compete with our Remote LIBERTY technology patents that essentially eliminate radiation effects and acquiring us for our IP won’t be cheap! ✌️
0 · Reply
roejohn
roejohn May. 29 at 6:17 PM
$SYK $SENS , has an approved implantable CGM , FDA and Medicare . The combination of SYK and SENS makes sense . SENS is a necessity ! EVERSENSE 365
0 · Reply
Ro_Patel
Ro_Patel May. 26 at 6:04 PM
Drawdowns & recoveries of US stocks w/ highest & lowest total shareholder returns from 1985 to 2024 $BRO $SYK $EXPD $SHW $AMGN Note: Many of the big tech co.s today, such as Tesla and even Amazon & Nvidia, had their IPOs much later than 1985
1 · Reply
SteveJohnsonis
SteveJohnsonis May. 23 at 1:22 PM
0 · Reply
inspector_gadget86
inspector_gadget86 May. 19 at 8:04 PM
$SYK Stryker Receives FDA Clearance For OptaBlate System Aimed At Low Back Pain Relief
0 · Reply
ProbablyJustABot
ProbablyJustABot May. 19 at 5:22 PM
$SYK Bought in and found there is also a teeny dividend. Seems like a decent bet atm. Needs volume though. Stryker (NYSE:SYK) has received FDA 510(k) clearance for its OptaBlate basivertebral nerve ablation system (OptaBlate BVN), designed to treat chronic vertebrogenic low back pain. The system represents a minimally invasive solution that targets the basivertebral nerve for long-lasting pain relief. Key features include achieving a 1 cm lesion in 7 minutes, steerable curved introducer, microinfusion technology for hydration, and 10-gauge access tools. This addition expands Stryker's pain management portfolio, combining their expertise in radiofrequency ablation technology and vertebral access. The system will be showcased at the American Society of Pain & Neuroscience Annual Meeting in Miami, FL, July 17-20.
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 19 at 5:04 PM
$SYK just scored FDA clearance for its OptaBlate BVN system - a potential game changer in chronic back pain treatment. With 5-year efficacy data and proprietary microinfusion tech, this could be the growth catalyst their pain portfolio needs. At 53x P/E, the market's clearly pricing in execution...but today's news shows why they command premium multiples. https://www.prnewswire.com/news-releases/stryker-receives-fda-clearance-for-optablate-bvn-basivertebral-nerve-ablation-system-302459050.html
0 · Reply
Thelonius_Stonk
Thelonius_Stonk May. 15 at 11:48 PM
$SYK i didn't buy it lfg
0 · Reply
WickCrawlerx
WickCrawlerx May. 13 at 1:30 PM
$SYK Stumbled on a pretty useful tool lately. It tracks price action and sends real-time alerts when a ticker starts moving fast, breaks key levels, or shows unusual volume. Helps me catch momentum plays early - before they show up on everyone’s radar. The interface is clean, no clutter. You can filter by sectors or categories, and the alerts are instant - no delays like with some scanners. It's helped me avoid noise and focus on the action that actually matters. If you're an active trader, it’s definitely worth a look. Small edge, big difference.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 13 at 11:57 AM
A detailed forecast of the post-earnings announcement drift (PEAD) for $SYK, evaluating the stock's anticipated price movements and momentum following its most recent earnings report, based on historical trends and market reactions. #stocks #trading #investing
0 · Reply
CroatoanCapital
CroatoanCapital May. 9 at 2:41 PM
$MBOT I couldn't ask for a better chart setup. Breakout of the cup and handle looks imminent. Above about $2.70 on volume and we'll head to $4.10. The key for me is up on high volume and retreat on lower volume (duh, right?). The odds of clearance are going up each day that passes. Or down, if you are a pessimist. Considering the amazing results of the trials with 100% success and 100% operator satisfaction, plus all other requirements fulfilled, I am very optimistic. Stryker has a development agreement with $MBOT to incorporate Stryker's neurovascular devices with Microbot's robot and create a robotic neuro package. Stryker ($SYK) is a $146 Billion dollar company. They could swallow $MBOT as a light snack. They would have the whole enchilada in peripheral, coronary and neuro. Some good connections between the company principals too. Looking forward to clearance. I think volume will be over 40 million on clearance day and fireworks will last at least a few days.
1 · Reply
BullBites
BullBites May. 8 at 9:33 PM
Today's Insider Trades Top Purchases: 1. $UTGN, worth $7.0M (avg. $40.0) 2. $CBRL, worth $2.4M (avg. $44.6) 3. $SLN, worth $980K (avg. $3.9) Top Sales: 1. $SYK, worth $75.4M (avg. $377.0) 2. $ABNB, worth $26.3M (avg. $122.8) 3. $KLAC, worth $7.4M (avg. $683.3)
0 · Reply
ILikeStonksNow
ILikeStonksNow May. 8 at 1:41 PM
$NMTC A big med device company should scoop up $NMTC now while it’s still early. They’ve got FDA-cleared tech for brain disorders and pain that’s less invasive and cheaper than what’s out there today. The neuro space is growing fast, and $NMTC’s already cleared key regulatory hurdles. They’re ready to scale but need more muscle behind them. This is a no-brainer bolt-on that could punch above its weight for companies like $ABT, $BSX, $SYK, or $ZBH looking to expand in neuromodulation and brain health.
1 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 7 at 11:48 AM
Projected 90-day price trajectory for $SYK based on historical trends, earnings impact, and momentum indicators, offering a forward-looking view of potential market movement. #stocks #trading #investing
0 · Reply
JarvisFlow
JarvisFlow May. 5 at 4:33 PM
Truist Securities has adjusted their stance on Stryker ( $SYK ), setting the rating to Hold with a target price of 390 → 400.
0 · Reply